Erlangen, Germany

Isolde Strobel


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal1 out of 8 
 
University of Antwerp
 patents
silverMedal1 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Isolde Strobel: Innovator in Gene Delivery Technology

Introduction

Isolde Strobel is a prominent inventor based in Erlangen, Germany. She has made significant contributions to the field of gene delivery, particularly in the transfection of eukaryotic cells. Her innovative methods have the potential to enhance therapeutic applications in medicine.

Latest Patents

Isolde Strobel holds a patent for her invention titled "Transfection of eukaryontic cells with linear polynucleotides by electroporation." This patent describes an improved method for gene delivery in eukaryotic cells, specifically targeting human hematopoietic cells, including dendritic cells. The method she developed is superior to traditional techniques such as lipofection and passive pulsing of mRNA, as well as electroporation of plasmid cDNA for gene delivery, including tumor antigen loading of dendritic cells. She has 1 patent to her name.

Career Highlights

Throughout her career, Isolde has worked with various institutions, including the University of Antwerp. Her research has focused on advancing gene delivery techniques, which are crucial for developing new therapies in the medical field.

Collaborations

Isolde has collaborated with notable professionals in her field, including Gerold Schuler and Zwi N Berneman. These partnerships have contributed to her innovative research and the advancement of gene delivery technologies.

Conclusion

Isolde Strobel is a trailblazer in the field of gene delivery, with her patented methods offering promising advancements in medical therapies. Her work continues to influence the landscape of genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…